Moore Law,PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against:
https://mma.prnewswire.com/media/698123/Moore_Kuehn_Logo.jpg
— Hims & Hers Health, Inc. (NYSE: HIMS)
— Shareholders should emailFletcher@fmoorelaw.com
The investigation concerns a recent announcement about the Novo Nordisk collaboration.
OnApril 29, 2025, Hims & Hers announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of “a bundled offering of Novo Nordisk's FDA-approved Wegovy® on the Hims & Hers platform.” Then, onJune 23, 2025, NovoNordisk issued a press release announcing that it was terminating its partnership with Hims & Hers, citing “Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk.” The press release stated thatHims & Hers “has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization.''' The press release further stated that “[b]ased on Novo Nordisk's investigation, the 'semaglutide' active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers inChina” which “FDA has never authorized or approved and which may contain unsafe and illicit foreign ingredients.”
On this news, Hims & Hers' stock price fell$22.24per share, or 34.63%, to close at$41.98per share onJune 23, 2025.
If you ownHims & Hers Health, Inc. (NYSE: HIMS) stock, please contactFletcher Moore by email atfletcher@fmoorelaw.com.
You may be able to seek monetary damages, corporate governance reforms, reimbursement to the company, and a court approved incentive award at no cost to you whatsoever. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
https://c212.net/c/img/favicon.png?sn=NY26237&sd=2025-07-08
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-action-notice-moore-law-pllc-encourages-investors-in-hims–hers-health-inc-to-contact-law-firm-302500435.html
SOURCE Moore Law PLLC
https://rt.newswire.ca/rt.gif?NewsItemId=NY26237&Transmission_Id=202507081519PR_NEWS_USPR_____NY26237&DateId=20250708